pyrrolidine dithiocarbamate has been researched along with Infection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, MR; Bobryshev, YV; Kavurma, MM; Khachigian, LM; Schoppet, M | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Infection
| Article | Year |
|---|---|
TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappaB and induction of insulin-like growth factor-1 receptor.
Topics: Antioxidants; Apoptosis; Autoimmune Diseases; Caspase 3; Cell Proliferation; Cells, Cultured; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Gene Expression Regulation; GPI-Linked Proteins; Humans; Infections; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Proliferating Cell Nuclear Antigen; Pyrrolidines; Receptor, IGF Type 1; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 10c; Thiocarbamates; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor RelA; Transplants; Tumor Necrosis Factor Decoy Receptors | 2008 |